First Time Loading...

Novozymes A/S
CSE:NZYM B

Watchlist Manager
Novozymes A/S Logo
Novozymes A/S
CSE:NZYM B
Watchlist
Price: 403 DKK -3.93%
Updated: Jun 11, 2024

Novozymes A/S
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Novozymes A/S
Cost of Revenue Peer Comparison

Comparables:
CHR

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Novozymes A/S
CSE:NZYM B
Cost of Revenue
-kr8.2B
CAGR 3-Years
-10%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Chr Hansen Holding A/S
CSE:CHR
Cost of Revenue
-€611.1m
CAGR 3-Years
-17%
CAGR 5-Years
-4%
CAGR 10-Years
-6%

See Also

What is Novozymes A/S's Cost of Revenue?
Cost of Revenue
-8.2B DKK

Based on the financial report for Dec 31, 2023, Novozymes A/S's Cost of Revenue amounts to -8.2B DKK.

What is Novozymes A/S's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-6%

Over the last year, the Cost of Revenue growth was -3%. The average annual Cost of Revenue growth rates for Novozymes A/S have been -10% over the past three years , -6% over the past five years .